Development of mRNA–lipid nanoparticle intrabodies against rickettsial infection
Abstract Background Rickettsiosis is among the deadliest vector-borne infectious diseases worldwide, in part because rickettsiae replicate within human cells, where antibodies and most drugs cannot effectively reach this obligatory intracellular pathogen. Ehrlichia chaffeensis, an emerging rickettsi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-08-01
|
| Schriftenreihe: | Journal of Biomedical Science |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12929-025-01171-5 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
